Activities of BMS 284756 (T-3811) against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from SENTRY Antimicrobial Surveillance Program Medical Centers in Latin America (1999)

被引:18
作者
Gales, A [1 ]
Sader, H [1 ]
Jones, RN [1 ]
机构
[1] Univ Iowa, Coll Med, Iowa City, IA 52242 USA
关键词
D O I
10.1128/AAC.45.5.1463-1466.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The antimicrobial activity of EMS 284756, a novel des-F(6)-quinolone, was comparatively evaluated against 257 Streptococcus pneumoniae, 198 Haemophilus influenzae, and 88 Moraxella catarrhalis strains isolated in Latin America between July and September of 1999 as part of the SENTRY Antimicrobial Surveillance Program. Nearly 28.0% of S. pneumoniae strains were nonsusceptible to penicillin. The rank order of quinolone potency versus S. pneumoniae was EMS 284756 (MIC at which 90% of isolates were inhibited [MIC90], 0.12 mug/ml) > trovafloxacin (MIC90, 0.25 mug/ml) > gatifloxacin (MIC90, 0.5 mug/ml) > levofloxacin and ciprofloxacin (MIC90, 1 to 2 mug/ml). All S. pneumoniae strains that were not susceptible to other quinolones were inhibited by EMS 284756 at less than or equal to 2 mug/ml. The overall prevalence of beta -lactamase production was 15.2% in H. influenzae and 98.9% in M. catarrhalis. EMS 284756 showed excellent potency and spectrum against this group of pathogens, inhibiting all isolates at less than or equal to0.12 mug/ml. EMS 284756 exhibited activity similar to those displayed by the new fluoroquinolones, such as levofloxacin, trovafloxacin, or gatifloxacin, and could be a therapeutic option for empirical treatment of community-acquired respiratory tract infections.
引用
收藏
页码:1463 / 1466
页数:4
相关论文
共 7 条
  • [1] Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin
    Bauernfeind, A
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (05) : 639 - 651
  • [2] Comparative activity of clinafloxacin AND nine other compounds tested against 2000 contemporary clinical isolates from patients in United States hospitals
    Deshpande, LM
    Diekema, DJ
    Jones, RN
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 35 (01) : 81 - 88
  • [3] Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections:: Antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)
    Doern, GV
    Jones, RN
    Pfaller, MA
    Kugler, K
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (02) : 385 - 389
  • [4] Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H-influenzae
    Jones, RN
    Biedenbach, DJ
    Erwin, ME
    Beach, ML
    Pfaller, MA
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (06) : 1999 - 2002
  • [5] *NAT COMM CLIN LAB, 2000, PERF STAND ANT SUSC
  • [6] *NAT COMM CLIN LAB, 2000, METH DIL ANT TESTS B
  • [7] In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone
    Takahata, M
    Mitsuyama, J
    Yamashiro, Y
    Yonezawa, M
    Araki, H
    Todo, Y
    Minami, S
    Watanabe, Y
    Narita, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) : 1077 - 1084